{
  "id": "fda_guidance_chunk_0686",
  "title": "Introduction - Part 686",
  "text": "with activity Some interference with activity Significant; prevents daily activity ER visit or hospitalization Contains Nonbinding Recommendations Systemic Illnes Mild (Grade 1) (Moderate(Grade 2) Severe (Grade 3) Potentially Life Threatening (Grade 4) Illness or clinical adverse event (as defined according to applicable regulations) No interference with activity Some interference with activity not requiring medical intervention Prevents daily activity and requires medical intervention ER visit or hospitalization Contains Nonbinding Recommendations B. Tables for Laboratory Abnormalities The laboratory values provided in the tables below serve as guidelines and are dependent upon institutional normal parameters. Institutional normal reference ranges should be provided to demonstrate that they are appropriate. Serum * Mild (Grade 1) Moderate (Grade 2) Severe (Grade 3) Potentially Life Threatening (Grade 4)** Sodium – Hyponatremia mEq/L 132 – 134 130 – 131 125 – 129 < 125 Sodium – Hypernatremia mEq/L 144 – 145 146 – 147 148 – 150 > 150 Potassium – Hyperkalemia mEq/L 5.1 – 5.2 5.3 – 5.4 5.5 – 5.6 > 5.6 Potassium – Hypokalemia mEq/L 3.5 – 3.6 3.3 – 3.4 3.1 – 3.2 < 3.1 Glucose – Hypoglycemia mg/dL 65 – 69 55 – 64 45 – 54 < 45 Glucose – Hyperglycemia Fasting – mg/dL Random – mg/dL 100 – 110 110 – 125 111 – 125 126 – 200 >125 >200 Insulin requirements or hyperosmolar coma Blood Urea Nitrogen BUN mg/dL 23 – 26 27 – 31 > 31 Requires dialysis Creatinine – mg/dL 1.5 – 1.7 1.8 – 2.0 2.1 – 2.5 > 2.5 or requires dialysis Calcium – hypocalcemia mg/dL 8.0 – 8.4 7.5 – 7.9 7.0 – 7.4 < 7.0 Calcium – hypercalcemia mg/dL 10.5 – 11.0 11.1 – 11.5 11.6 – 12.0 > 12.0 Magnesium – hypomagnesemia mg/dL 1.3 – 1.5 1.1 – 1.2 0.9 – 1.0 < 0.9 Phosphorous – hypophosphatemia mg/dL 2.3 – 2.5 2.0 – 2.2 1.6 – 1.9 < 1.6 CPK – mg/dL 1.25 – 1.5 x ULN*** 1.6 – 3.0 x ULN 3.1 –10 x ULN > 10 x ULN Albumin – Hypoalbuminemia g/dL 2.8 – 3.1 2.5 – 2.7 < 2.5 -- Total Protein – Hypoproteinemia g/dL 5.5 – 6.0 5.0 – 5.4 < 5.0 -- Alkaline phosphate – increase by factor 1.1 – 2.0 x ULN 2.1 – 3.0 x ULN 3.1 – 10 x",
  "source": "FDA_clinical_trial_guidance.txt",
  "section_heading": "Introduction",
  "start_pos": 920640,
  "end_pos": 922176,
  "tokens": 512,
  "tags": [
    "safety"
  ],
  "jurisdiction": "US",
  "document_type": "fda_guidance",
  "guidance_section": "general_guidance",
  "regulatory_weight": "guidance",
  "created_at": "2025-10-23T02:25:44.731Z"
}